J
Jean-Marie Moutquin
Researcher at Université de Sherbrooke
Publications - 32
Citations - 2824
Jean-Marie Moutquin is an academic researcher from Université de Sherbrooke. The author has contributed to research in topics: Pregnancy & Preeclampsia. The author has an hindex of 15, co-authored 32 publications receiving 2619 citations. Previous affiliations of Jean-Marie Moutquin include University of Toronto & Centre Hospitalier Universitaire de Sherbrooke.
Papers
More filters
Journal ArticleDOI
The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
TL;DR: The classification and diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Vol. 20, No. 1, pp. ix-xiv as mentioned in this paper.
Journal ArticleDOI
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
Peter von Dadelszen,Beth A. Payne,Jing Li,J. Mark Ansermino,Fiona Broughton Pipkin,Anne-Marie Côté,M. Joanne Douglas,Andrée Gruslin,Jennifer A. Hutcheon,K.S. Joseph,Phillipa M. Kyle,Tang Lee,Pamela Loughna,Jennifer Menzies,Mario Merialdi,Alexandra L. Millman,M. Peter Moore,Jean-Marie Moutquin,Annie Ouellet,Graeme N. Smith,James J. Walker,Keith R. Walley,Barry N J Walters,Mariana Widmer,Shoo K. Lee,James A. Russell,Laura A. Magee +26 more
TL;DR: In this paper, the authors developed and validated the fullPIERS model with the aim of identifying the risk of fatal or life-threatening complications in women with pre-eclampsia within 48 h of hospital admission for the disorder.
Journal ArticleDOI
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour
Jean-Marie Moutquin,Dominique Cabrol,Nicholas M. Fisk,Alastair H. MacLennan,Karel Marsal,J. Rabinovici +5 more
TL;DR: The effectiveness and safety of the oxytocin antagonist atosiban with conventional beta‐adrenergic agonist (beta‐agonist) therapy in the treatment of preterm labour is compared.
Journal ArticleDOI
Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia.
TL;DR: The findings showed an inverse correlation between increased levels of H(2)O(2), a terminal metabolite of the cellular oxidative stress cascade, and decreased levels of NO early in maternal circulation and at term in placenta of women with preeclampsia.
Journal ArticleDOI
Low-dose ASA response using the PFA-100 in women with high-risk pregnancy.
Nadia Caron,Georges-Etienne Rivard,Nicole Michon,Francine Morin,Danielle Pilon,Jean-Marie Moutquin,Evelyne Rey +6 more
TL;DR: A significant number of pregnant women showed a lack of platelet function response to ASA 81 mg that was in most cases overcome with higher dosing, and the prevalence of non-responsiveness increased with advancing pregnancy.